key: cord-0015474-ebhmwcgl
authors: Craig, Amanda M.; Hughes, Brenna L.; Swamy, Geeta K.
title: Re: Letter to the editor re: COVID-19 Vaccines in Pregnancy
date: 2021-02-20
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2021.100337
sha: 3c37cda17fe00882f40a7fcdf213bc904e26eb35
doc_id: 15474
cord_uid: ebhmwcgl

nan

Dear Dr. Al-Lami, Thank you for your interest in our article. Given the lack of available data on use of vaccine in pregnancy to date, we agree that pregnant women should weigh their own personal risk of COVID-19 exposure and disease severity with the continued accumulating data that COVID-19 poses significant maternal risks if infected during pregnancy. [1] Your letter raises the theoretical concern of increased contractions related to impairment of the ACE receptor. We are aware of no data suggesting that the mRNA vaccines downregulate ACE receptors. In vaccine clinical trials, there were no exclusions of individuals using ACE inhibitors or ACE2 receptor antagonists for hypertension, nor were there any concerns raised or complications for individuals with hypertension.

The mechanism of action of mRNA-based vaccines is to induce a cellular and humoral immune response and do not contain live virus. ACOG and SMFM recommend that given the clear maternal benefits provided by vaccine in the absence of known harm of vaccine, that pregnant women should have access to these COVID-19 vaccines in all phases of vaccine distribution. [2] Given the lack of inclusion of pregnant women in vaccine clinical trials, we acknowledge that long-term maternal, fetal, and neonatal impacts are unknown due to lack of available data. For this reason, it will be important to continue to collect data through observational studies and surveillance systems like VSAFE, as well as clinical trials aimed at enrolling pregnant women, in order to appropriately continue to counsel individuals in the preconception, antepartum, and postpartum period. 

Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19

Society for Maternal-Fetal Medicine (SMFM) Statement: SARS-CoV-2 Vaccination in Pregnancy